V-01

V-01 is a protein subunit COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc. __TOC__ == Preclinical studies ==

~1 min read

Article

3 sections

Contents

Preclinical studies
Clinical studies
References

V-01 is a protein subunit COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc. __TOC__ == Preclinical studies ==

A preclinical study in rhesus macaques was published in July 2021. The vaccine's ability to neutralize several variants of concern has also been tested in mice. Another study in mice tested V-01 as a booster after inactivated Covid vaccine, including neutralization of a range of variants of concern.